- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case C-589/23, Cassella-med and MCM Klosterfrau: Request for a preliminary ruling from the Bundesgerichtshof (Germany) lodged on 25 September 2023 — Cassella-med GmbH & Co. KG, MCM Klosterfrau Vertriebsgesellschaft mbH v Verband Sozialer Wettbewerb e.V.
ECLI:EU:UNKNOWN:62023CN0589
62023CN0589
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
EN
Series C
C/2024/706
22.1.2024
(Case C-589/23, Cassella-med and MCM Klosterfrau)
(C/2024/706)
Language of the case: German
Referring court
Parties to the main proceedings
Defendants and appellants in the appeal on a point of law: Cassella-med GmbH & Co. KG, MCM Klosterfrau Vertriebsgesellschaft mbH
Applicant and respondent in the appeal on a point of law: Verband Sozialer Wettbewerb e.V.
Question referred
Is there a pharmacological action within the meaning of the first case in Article 1(2)(b) of Directive 2001/83/EC (1) where the substance in question (in this case: D-mannose), by means of a reversible binding to bacteria via hydrogen bonds, prevents the bacteria from adhering to human cells (in this case: the bladder wall)?
Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ 2001 L 311, p. 67).
ELI: http://data.europa.eu/eli/C/2024/706/oj
ISSN 1977-091X (electronic edition)